PCT/US2011/023154
COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN HDAC INHIBITOR
Details for PCT/US2011/023154
LEE, Ho-Young
Dates
Deadlines
Abstract
Info
PCT Patent application PCT/US2011/023154 was filed on January 31, 2011 by BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; LEE, Ho-Young. The title of this PCT Patent Application is "COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN HDAC INHIBITOR" and the patent specification was published as WO/2011/097166 on August 11, 2011.
The earliest priority date for the patent application is February 2, 2010 and therefore the 30 month national phase deadline for PCT/US/2011/023154 is August 2, 2012 and the 31 month national phase deadline for PCT/US/2011/023154 is September 2, 2012
Legal
The information provided herein is not legal or other professional advice. The information herein may be provided from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein.